Functional polymorphisms of the leptin and leptin receptor genes are associated with longevity and with the risk of myocardial infarction and of type 2 diabetes mellitus

Endokrynologia Polska

Volumn 65, Issue 1, 2014, Pages 11-16

  Roszkowska Gancarz, Małgorzata ^a   Kurylowicz, Alina ^b   Polosak, Jacek ^a,b   Mossakowska, Małgorzata ^c   Franek, Edward ^b   Puzianowska Kuźnicka, Monika ^a,b  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^c INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Centenarians; Leptin gene (LEP); Leptin receptor gene (LEPR); Longevity; Myocardial infarction (MI); Polymorphism; Type 2 diabetes mellitus (DM2)

Indexed keywords

LEPTIN; LEPTIN RECEPTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HETEROZYGOTE; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ADOLESCENT; AGED; CONTROLLED CLINICAL TRIAL; CROSS-SECTIONAL STUDY; GENETIC PREDISPOSITION; GENETICS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEPTIN; LONGEVITY; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RECEPTORS, LEPTIN; YOUNG ADULT;

EID: 84896715893     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: 10.5603/EP.2014.0002     Document Type: Article

References (54)

1. Zhang F, Chen Y, Heiman M et al. Leptin: structure, function and biology. Vitam Horm 2005; 71: 345-372.
2. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev 2007; 8: 21-34.
3. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord 2002; 26: 1407-1433.
4. Sánchez-Margalet V, Martín-Romero C, Santos-Alvarez J et al. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action. Clin Exp Immunol 2003; 133: 11-19.
5. Coen G. Leptin and bone metabolism. J Nephrol 2004; 17: 187-189.
6. Koroglu BK, Kiris F, Ersoy IH et al. Relation of leptin, adiponectin and insulin resistance to bone mineral density in type 2 diabetic postmenopausal women. Endokrynol Pol 2011; 62: 429-435.
7. Cases JA, Gabriely I, Ma XH et al. Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes 2001; 50: 348-352.
8. Tucholski K, Otto-Buczkowska E. The role of leptin in the regulation of carbohydrate metabolism. Endokrynol Pol 2011; 62: 258-262.
9. Cervero A, Domínguez F, Horcajadas JA et al. The role of the leptin in reproduction. Curr Opin Obstet Gynecol 2006; 18: 297-303.
10. Anagnostoulis S, Karayiannakis AJ, Lambropoulou M et al. Human leptin induces angiogenesis in vivo. Cytokine 2008; 42: 353-357.
11. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000; 68: 437-446.
12. Frühbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006; 393: 7-20.
13. Smirnoff P, Almiral-Seliger D, Schwartz B. Serum leptin levels in the elderly: relationship with gender and nutritional status. J Nutr Health Aging 2001; 5: 29-32.
14. Ruhl CE, Everhart JE, Ding J et al. Serum leptin concentrations and body adipose measures in older black and white adults. Am J Clin Nutr 2004; 80: 576-583.
15. Isidori AM, Strollo F, Morè M et al. Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 2000; 85: 1954-1962.
16. Ma XH, Muzumdar R, Yang XM et al. Aging is associated with resistance to effects of leptin on fat distribution and insulin action. J Gerontol A Biol Sci Med Sci 2002; 57: B225-B231.
17. Parhami F, Tintut Y, Ballard A et al. Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res 2001; 88: 954-960.
18. Corsonello A, Malara A, De Domenico D et al. Identifying pathways involved in leptin-dependent aggregation of human platelets. Int J Obes Relat Metab Disord 2004; 28: 979-984.
19. Porreca E, Di Febbo C, Moretta V et al. Circulating leptin is associated with oxidized LDL in postmenopausal women. Atherosclerosis 2004; 175: 139-143.
20. Mendoza-Núñez VM, Correa-Muñoz E, Garfias-Cruz EA, Sánchez-Rodriguez MA, Galván-Duarte RE, Retana-Ugalde R. Hyperleptinemia as a risk factor for high blood pressure in the elderly. Arch Pathol Lab Med 2006; 130: 170-175.
21. Perry HM 3rd, Morley JE, Horowitz M et al. Body composition and age in African-American and Caucasian women: relationship to plasma leptin levels. Metabolism 1997; 46: 1399-1405.
22. Kalra SP. Disruption in the leptin-NPY link underlies the pandemic of diabetes and metabolic syndrome: new therapeutic approaches. Nutrition 2008; 24: 820-826.
23. Kim SK, Kim HJ, Ahn CW et al. Hyperleptinemia as a robust risk factor of coronary artery disease and metabolic syndrome in type 2 diabetic patients. Endocr J 2008; 55: 1085-1092.
24. Söderberg S, Stegmayr B, Ahlbeck-Glader C et al. High leptin levels are associated with stroke. Cerebrovasc Dis 2003; 15: 63-69.
25. Bienek R, Marek B, Kajdaniuk D et al. Adiponectin, leptin, resistin and insulin blood concentrations in patients with ischaemic cerebral stroke. Endokrynol Pol 2012; 63: 338-345.
26. Ushiroyama T, Ikeda A, Hosotani T et al. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol 2003; 17: 31-36.
27. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol 2006; 207: 12-22.
28. Mossakowska M, Barcikowska M, Broczek K et al. Polish Centenarians Programme. Multidisciplinary studies of successful ageing: aims, methods, and preliminary results. Exp Gerontol 2008; 43: 238-244.
29. Bledowski P, Mossakowska M, Chudek J et al. Medical, psychological and socioeconomic aspects of aging in Poland: assumptions and objectives of the PolSenior project. Exp Gerontol 2011; 46: 1003-1009.
30. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 1988; 16: 1215.
31. Méndez-Sánchez N, Bermejo-Martínez L, Chávez-Tapia NC et al. Obesity-related leptin receptor polymorphisms and gallstones disease. Ann Hepatol 2006; 5: 97-102.
32. Baranowska B, Bik W, Baranowska-Bik A et al. Neuroendocrine control of metabolic homeostasis in Polish centenarians. J Physiol Pharmacol 2006; 57 (Suppl. 6): 55-61.
33. Mammès O, Betoulle D, Aubert R et al. Association of the G-2548A polymorphism in the 5' region of the LEP gene with overweight. Ann Hum Genet 2000; 64: 391-394.
34. Wang TN, Huang MC, Chang WT et al. G-2548A polymorphism of the leptin gene is correlated with extreme obesity in Taiwanese aborigines. Obesity 2006; 14: 183-187.
35. Skibola CF, Holly EA, Forrest MS et al. Body mass index, leptin and leptin receptor polymorphisms, and non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev 2004; 13: 779-786.
36. Ribeiro R, Vasconcelos A, Costa S et al. Overexpressing leptin genetic polymorphism (-2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease. Prostate 2004; 59: 268-274.
37. Ribeiro R, Araújo AP, Coelho A et al. A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer. Eur J Cancer 2006; 42: 1188-1193.
38. Snoussi K, Strosberg AD, Bouaouina N et al. Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma. BMC Cancer 2006; 6: 38.
39. Okobia MN, Bunker CH, Garte SJ et al. Leptin receptor Gln223Arg polymorphism and breast cancer risk in Nigerian women: a case control study. BMC Cancer 2008; 8: 338.
40. Han CZ, Du LL, Jing JX et al. Associations among lipids, leptin, and leptin receptor gene Gln223Arg polymorphisms and breast cancer in China. Biol Trace Elem Res 2008; 126: 38-48.
41. Yapijakis C, Kechagiadakis M, Nkenke E et al. Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol 2009; 135: 603-612.
42. Partida-Pérez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J et al. Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark 2010; 7: 117-121.
43. Nyante SJ, Gammon MD, Kaufman JS et al. Common genetic variation in adiponectin, leptin, and leptin receptor and association with breast cancer subtypes. Breast Cancer Res Treat 2011; 129: 593-606.
44. Mizuta E, Kokubo Y, Yamanaka I et al. Leptin gene and leptin receptor gene polymorphisms are associated with sweet preference and obesity. Hypertens Res 2008; 31: 1069-1077.
45. Salopuro T, Pulkkinen L, Lindström J et al. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: the Finnish Diabetes Prevention Study. Int J Obes 2005; 29: 1245-1251.
46. Yiannakouris N, Yannakoulia M, Melistas L et al. The Q223R polymorphism of the leptin receptor gene is significantly associated with obesity and predicts a small percentage of body weight and body composition variability. J Clin Endocrinol Metab 2001; 86: 4434-4439.
47. Masuo K, Straznicky NE, Lambert GW et al. Leptin-receptor polymorphisms relate to obesity through blunted leptin-mediated sympathetic nerve activation in a Caucasian male population. Hypertens Res 2008; 31: 1093-1100.
48. Gottlieb MG, Bodanese LC, Araújo Leite LE et al. Association between the Gln223Arg polymorphism of the leptin receptor and metabolic syndrome in free-living community elderly. Metab Syndr Relat Disord 2009; 7: 341-348.
49. Chiu KC, Chu A, Chuang LM et al. Association of leptin receptor polymorphism with insulin resistance. Eur J Endocrinol 2004; 150: 725-729.
50. Takahashi-Yasuno A, Masuzaki H, Miyawaki T et al. Leptin receptor polymorphism is associated with serum lipid levels and impairment of cholesterol lowering effect by simvastatin in Japanese men. Diabetes Res Clin Pract 2003; 62: 169-175.
51. Sun YM, Wang LF, Li J et al. The 223A > G polymorphism of the leptin receptor gene and lipid-lowering efficacy of simvastatin in Chinese patients with coronary heart disease. Eur J Clin Pharmacol 2009; 65: 157-161.
52. Tirosh A, Shai I, Tekes-Manova D et al. Normal fasting plasma glucose levels and type 2 diabetes in young men. N Engl J Med 2005; 353: 1454-1462.
53. Hayashino Y, Fukuhara S, Suzukamo Y et al. Normal fasting plasma glucose levels and type 2 diabetes: the high-risk and population strategy for occupational health promotion (HIPOP-OHP) [corrected] study. Acta Diabetol 2007; 44: 164-166.
54. Nichols GA, Hillier TA, Brown JB. Normal fasting plasma glucose and risk of type 2 diabetes diagnosis. Am J Med 2008; 121: 519-524.